IMMUNO-COV Trademark Information

Trademark by Regeneron Pharmaceuticals, Inc.

Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease antibody detection, namely, for identifying antibodies that neutralize the SARS-CoV-2 virus in patient blood samples

Classification Information

Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
General Information
Word mark: IMMUNO-COV
Status/Status Date:
FIRST EXTENSION - GRANTED
4/15/2021
Serial Number: 88906096
Filing Date: 5/7/2020
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease antibody detection, namely, for identifying antibodies that neutralize the SARS-CoV-2 virus in patient blood samples
Mark Description: NOT AVAILABLE
Type Of Mark: TradeMark
Published For Opposition Date: 9/8/2020
Last Applicant/Owner:
Regeneron Pharmaceuticals, Inc.
Tarrytown, NY 10591
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
OHLANDT, GREELEY, RUGGIERO & PERLE, LLP
10TH FLOOR
ONE LANDMARK SQUARE
STAMFORD CT 06901
Current Status:
FIRST EXTENSION - GRANTED
4/15/2021
Correspondent Search:
TERRENCE J. MCALLISTER is a correspondent of IMMUNO-COV trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on